Biomarkers in rheumatoid arthritis

Affiliations

¹ Rheumatology Department, Research Units EA 4666 & Inserm U1088, Amiens University Hospital, University of Picardie Jules-Verne, 80054 Amiens, France.
² Rheumatology Department, Strasbourg University Hospital, Strasbourg, France.
³ Leeds Institute of Rheumatic and Musculoskeletal Medicine, The University of Leeds, Leeds, UK.

Editorial

Vincent Goëb et al. Mediators Inflamm. 2014.

. 2014:2014:379310.

doi: 10.1155/2014/379310. Epub 2014 Jun 30.

¹ Rheumatology Department, Research Units EA 4666 & Inserm U1088, Amiens University Hospital, University of Picardie Jules-Verne, 80054 Amiens, France.
² Rheumatology Department, Strasbourg University Hospital, Strasbourg, France.
³ Leeds Institute of Rheumatic and Musculoskeletal Medicine, The University of Leeds, Leeds, UK.

No abstract available

References

1. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism. 2010;62(9):2569–2581. - PubMed
1. Krabben A, Abhishek A, Britsemmer K, et al. Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis. Rheumatology. 2013;52:1265–1270. - PubMed
1. Goëb V, Jouen F, Gilbert D, le Loët X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine. 2009;76(4):343–349. - PubMed
1. Burska AN, Roget K, Blits M, et al. Gene expression analysis in RA: towards personalized medicine. The Pharmacogenomics. 2014;14:93–106. - PMC - PubMed
1. Trouvin A-P, Goëb V. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clinical Interventions in Aging. 2010;5:345–354. - PMC - PubMed